Klaus‐Peter Knobeloch

9.4k citations

78 papers · 5.3k indexed · 1 hit paper · h-index 39

Immunology top 0.5%
Molecular Biology top 5%
Oncology top 2%
Epidemiology top 5%
Neurology top 1%

Co-authors: Ivan D. Horak Marco Prinz E Rohde Anja Basters Jürgen Löhler Olaf Utermöhlen Sandra Niendorf Frank Rosenbauer
Topics: interferon and immune responses (39 papers)Ubiquitin and proteasome pathways (19 papers)Immunotherapy and Immune Responses (14 papers)
Cited by: Immunology Neurology Immunology and Allergy
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Germany United States Switzerland

In The Last Decade

Klaus‐Peter Knobeloch

73 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene

1996 547 citations Jürgen Löhler, Yuka Kanno et al. Cell profile →

Peers

Countries citing papers authored by Klaus‐Peter Knobeloch

Since Specialization

Citations

This map shows the geographic impact of Klaus‐Peter Knobeloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus‐Peter Knobeloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus‐Peter Knobeloch more than expected).

Fields of papers citing papers by Klaus‐Peter Knobeloch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus‐Peter Knobeloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus‐Peter Knobeloch. The network helps show where Klaus‐Peter Knobeloch may publish in the future.

Co-authorship network of co-authors of Klaus‐Peter Knobeloch

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus‐Peter Knobeloch. A scholar is included among the top collaborators of Klaus‐Peter Knobeloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus‐Peter Knobeloch. Klaus‐Peter Knobeloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	USP8‐Governed MDA5 Homeostasis Promotes Innate Immunity and Autoimmunity 2025 ·Advanced Science ·Qimin Zhang,Shan Huang,(unknown),Weiwei Wang,Chao Tong,(unknown),Manyu Zhao,Lian Yi,Klaus‐Peter Knobeloch,Peijing Zhang	2
2	High‐Throughput Synthesis and Screening of a Cyanimide Library Identifies Selective Inhibitors of ISG15‐Specific Protease mUSP18 2025 ·Angewandte Chemie International Edition ·Raymond Kooij,(unknown),Gan Jin,(unknown),Ayşegül Sapmaz,(unknown),G. Fritz,Klaus‐Peter Knobeloch,Paul P. Geurink	0
3	In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases 2024 ·Frontiers in Molecular Biosciences ·(unknown),Klaus‐Peter Knobeloch	4
4	Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication 2023 ·Phytomedicine ·(unknown),(unknown),Luigi Marongiu,Natalia Ruétalo,(unknown),Christian Leischner,Christian Busch,Markus Burkard,Ulrich M. Lauer,Paul P. Geurink,Klaus‐Peter Knobeloch,Michael Schindler,G. Fritz,Sascha Venturelli	4
5	A comparative analysis of microglial inducible Cre lines 2023 ·Cell Reports ·Travis E. Faust,Philip A. Feinberg,Christopher M. O’Connor,Riki Kawaguchi,(unknown),(unknown),Maximilian Frosch,M BOYLE,Takahiro Masuda,Lukas Amann,Klaus‐Peter Knobeloch,Marco Prinz,Anne Schaefer,Dorothy P. Schafer	41
6	SCF ^Fbxw5 targets kinesin‐13 proteins to facilitate ciliogenesis 2021 ·The EMBO Journal ·(unknown),(unknown),Sandra Hess,(unknown),(unknown),(unknown),Shoji Hata,Klaus‐Peter Knobeloch,Frauke Melchior	10
7	Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell–Mediated Tumor Killing 2020 ·Cancer Discovery ·Jun-Bao Fan,Sayuri Miyauchi,Huizhong Xu,Dan Liu,Leo J.Y. Kim,Christoph Burkart,Hua Cheng,Kei‐ichiro Arimoto,Ming Yan,Yu Zhou,Balázs Győrffy,Klaus‐Peter Knobeloch,Jeremy N. Rich,Hu Cang,Xiang‐Dong Fu,Dong‐Er Zhang	42
8	Novel Hexb-based tools for studying microglia in the CNS 2020 ·Nature Immunology ·Takahiro Masuda,Lukas Amann,Roman Sankowski,Ori Staszewski,Maximilian Lenz,(unknown),Nicolas Snaidero,Marta Joana Costa Jordão,Chotima Böttcher,Katrin Kierdorf,Steffen Jung,Josef Priller,Thomas Misgeld,Andreas Vlachos,Melanie Meyer‐Luehmann,Klaus‐Peter Knobeloch,Marco Prinz	210
9	The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection 2019 ·Nature Communications ·Yifeng Zhang,Fabien Théry,Nicholas C. Wu,(unknown),Olivier Dussurget,Mariko H. Foecke,(unknown),Daniel J. Fernandez,Kevin Leandro,Antje Beling,Klaus‐Peter Knobeloch,Francis Impens,Pascale Cossart,Lilliana Radoshevich	63
10	Total chemical synthesis of murine ISG15 and an activity-based probe with physiological binding properties 2019 ·Organic & Biomolecular Chemistry ·Bo‐Tao Xin,Gan Jin,Daniel J. Fernandez,Klaus‐Peter Knobeloch,Paul P. Geurink,Huib Ovaa	12
11	DC Respond to Cognate T Cell Interaction in the Antigen-Challenged Lymph Node 2019 ·Frontiers in Immunology ·Caterina Curato,Biana Bernshtein,Eva Zupančič,Almut Dufner,Diego Adhemar Jaitin,Amir Giladi,Eyal David,Louise Chappell‐Maor,Dena Leshkowitz,Klaus‐Peter Knobeloch,Ido Amit,Helena F. Florindo,Steffen Jung	17
12	Structural basis of the specificity of USP18 toward ISG15 2017 ·Nature Structural & Molecular Biology ·Anja Basters,Paul P. Geurink,Annika Röcker,Katharina F. Witting,(unknown),Sandra Hess,Marta S. Semrau,Paola Storici,Huib Ovaa,Klaus‐Peter Knobeloch,G. Fritz	89
13	The A-kinase Anchoring Protein GSKIP Regulates GSK3β Activity and Controls Palatal Shelf Fusion in Mice 2015 ·Journal of Biological Chemistry ·(unknown),Philipp Skroblin,Carsten Dittmayer,Klaus‐Peter Knobeloch,Sebastian Bachmann,Enno Klußmann	12
14	Molecular characterization of ubiquitin‐specific protease 18 reveals substrate specificity for interferon‐stimulated gene 15 2014 ·FEBS Journal ·Anja Basters,Paul P. Geurink,Farid El Oualid,Lars Ketscher,(unknown),Eberhard Krause,Huib Ovaa,Klaus‐Peter Knobeloch,G. Fritz	43
15	IκB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-κB in the central nervous system 2011 ·Brain ·(unknown),Nicolas Zeller,Geert Loo,Doron Merkler,Alexander Mildner,Daniel Erny,Klaus‐Peter Knobeloch,John R. Bethea,Ari Waisman,(unknown),Domenico Del Turco,Thomas Deller,Thomas Blank,Josef Priller,Wolfgang Brück,Manolis Pasparakis,Marco Prinz	84
16	Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System 2008 ·Immunity ·Marco Prinz,Hauke Schmidt,Alexander Mildner,Klaus‐Peter Knobeloch,Uwe‐Karsten Hanisch,(unknown),Doron Merkler,Claudia N. Detje,Ilona Gutcher,Jörg Mages,Roland Lang,Roland Martinꝉ,Ralf Gold,Burkhard Becher,Wolfgang Brück,Ulrich Kalinke	318
17	IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses 2007 ·Proceedings of the National Academy of Sciences ·Deborah J. Lenschow,(unknown),Natalia Frias‐Staheli,Nadia V. Giannakopoulos,(unknown),Thorsten Wolff,(unknown),Beth Levine,Robert E. Schmidt,Adolfo Garcı́a-Sastre,David A. Leib,Andrew Pekosz,Klaus‐Peter Knobeloch,Ivan D. Horak,Herbert W. Virgin	436
18	Combined Loss of Hey1 and HeyL Causes Congenital Heart Defects Because of Impaired Epithelial to Mesenchymal Transition 2007 ·Circulation Research ·Andreas Fischer,Christian Steidl,Toni U. Wagner,(unknown),Peter M. Jakob,Peter Friedl,Klaus‐Peter Knobeloch,Manfred Gessler	138
19	A Regulatory Role for CD37 in T Cell Proliferation 2004 ·The Journal of Immunology ·Annemiek B. van Spriel,(unknown),Mariam Sofi,Dodie Pouniotis,Hubertus Hochrein,Zane Orinska,Klaus‐Peter Knobeloch,Magdalena Plebanski,Mark D. Wright	100
20	Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Genebreakdown → 1996 ·Cell ·(unknown),Jürgen Löhler,Yuka Kanno,Thomas Fehr,Nathalia A. Giese,Frank Rosenbauer,(unknown),Klaus‐Peter Knobeloch,Lucia Gabriele,Jeffrey F. Waring,Martin F. Bachmann,Rolf M. Zinkernagel,Herbert C. Morse,Keiko Ozato,Ivan D. Horak	547

About Klaus‐Peter Knobeloch

Klaus‐Peter Knobeloch is a scholar working on Immunology, Oncology and Molecular Biology, having authored 78 papers that have together received 5.3k indexed citations. Recurring topics across this work include interferon and immune responses (39 papers), Ubiquitin and proteasome pathways (19 papers) and Immunotherapy and Immune Responses (14 papers). The work is most often cited by research in Immunology (2.6k citations), Neurology (562 citations) and Immunology and Allergy (242 citations). Klaus‐Peter Knobeloch has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ivan D. Horak, Marco Prinz, E Rohde, Anja Basters, Jürgen Löhler, Olaf Utermöhlen, Sandra Niendorf, Frank Rosenbauer, Rolf M. Zinkernagel and G. Fritz. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact